HomeCompareRPHCF vs XYLD

RPHCF vs XYLD: Dividend Comparison 2026

RPHCF yields 1.82% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHCF wins by $43.20M in total portfolio value
10 years
RPHCF
RPHCF
● Live price
1.82%
Share price
$15.20
Annual div
$0.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.23M
Annual income
$39,107,153.37
Full RPHCF calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — RPHCF vs XYLD

📍 RPHCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHCFXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHCF + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHCF pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHCF
Annual income on $10K today (after 15% tax)
$154.90/yr
After 10yr DRIP, annual income (after tax)
$33,241,080.36/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, RPHCF beats the other by $33,238,344.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHCF + XYLD for your $10,000?

RPHCF: 50%XYLD: 50%
100% XYLD50/50100% RPHCF
Portfolio after 10yr
$21.63M
Annual income
$19,555,186.20/yr
Blended yield
90.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPHCF right now

RPHCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.2
Piotroski
5/9
XYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHCF buys
0
XYLD buys
0
No recent congressional trades found for RPHCF or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHCFXYLD
Forward yield1.82%10.98%
Annual dividend / share$0.28$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$43.23M$25.3K
Annual income after 10y$39,107,153.37$3,219.02
Total dividends collected$42.89M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RPHCF vs XYLD ($10,000, DRIP)

YearRPHCF PortfolioRPHCF Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$11,064$364.47$10,818$1,098.39+$246.00RPHCF
2$12,593$753.78$11,738$1,222.51+$855.00RPHCF
3$15,078$1,603.54$12,774$1,364.64+$2.3KRPHCF
4$19,722$3,588.75$13,944$1,527.86+$5.8KRPHCF
5$29,877$8,774.08$15,270$1,715.87+$14.6KRPHCF
6$56,812$24,844.41$16,775$1,933.09+$40.0KRPHCF
7$149,094$88,305.24$18,490$2,184.87+$130.6KRPHCF
8$592,694$433,162.94$20,450$2,477.63+$572.2KRPHCF
9$3,852,779$3,218,596.09$22,697$2,819.19+$3.83MRPHCF
10$43,229,627$39,107,153.37$25,280$3,219.02+$43.20MRPHCF

RPHCF vs XYLD: Complete Analysis 2026

RPHCFStock

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Full RPHCF Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this RPHCF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHCF vs SCHDRPHCF vs JEPIRPHCF vs ORPHCF vs KORPHCF vs MAINRPHCF vs QYLDRPHCF vs JEPQRPHCF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.